Kansas City-based health system signs cancer trial agreement

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

KANSAS CITY, Mo. (AP) _ A health system based in Kansas City, Missouri, has signed an agreement with Washington University in St. Louis that gives patients access to clinical trials through the university’s National Cancer Institute-supported research.

The Kansas City Star reports the agreement between St. Luke’s Health System and the university’s Alvin J. Siteman Cancer Center will take effect June 1. Patients should start having access to trials by late summer.

The partnership puts St. Luke’s in competition with the University of Kansas Health System, which has a National Cancer Institute-designated caner center. Siteman is considered a “comprehensive” cancer center, which is one step above Kansas’ designation.

National Cancer Institute spokeswoman Shannon Hatch says it’s pointless to compare the two because each will offer some treatments that the other doesn’t provide.
Information from: The Kansas City Star

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.